# New York Blood Center Enterprises – FDA Inspection, Feb 11, 2026

Source: https://www.keypedia.com/records/fda_inspections/new-york-blood-center-enterprises/773424e8-c0f3-4a89-b4fc-f157c4b9e3a8
Source feed: FDA_Inspections

> FDA inspection 1302348 of New York Blood Center Enterprises, February 11, 2026. 3 citations under 21 CFR part 606. Form 483 issued. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1302348
- Company Name: New York Blood Center Enterprises
- Inspection Date: 2026-02-11
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: New York District Office
- Citation Count: 3

## Related Documents

- FDA Inspection 1132998 - 2020-11-05
- FDA Inspection 1040884 - 2018-02-07
- FDA Inspection 952436 - 2015-12-02
- FDA Inspection 892079 - 2014-08-20
- FDA Inspection 797574 - 2012-09-05

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/irina-gaberman/c863b2de-4c64-40d2-a390-289d293e5a8f)

Company: https://www.keypedia.com/companies/new-york-blood-center-enterprises/64d20e9b-de77-469c-8cde-1ed160bda83d

Office: https://www.keypedia.com/offices/new-york-district-office/9fa3d265-16ca-438d-8a6e-b47f60dc260d